- Home
- ORKA vs AMSF Comparison
ORKA vs AMSF Comparison
Compare ORKA & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- AMSF
- Stock Information
- Founded
- ORKA 2004
- AMSF 1985
- Country
- ORKA United States
- AMSF United States
- Employees
- ORKA N/A
- AMSF N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AMSF Accident &Health Insurance
- Sector
- ORKA Health Care
- AMSF Finance
- Exchange
- ORKA Nasdaq
- AMSF Nasdaq
- Market Cap
- ORKA 354.2M
- AMSF 869.6M
- IPO Year
- ORKA N/A
- AMSF 2005
- Fundamental
- Price
- ORKA $14.21
- AMSF $44.16
- Analyst Decision
- ORKA Strong Buy
- AMSF Buy
- Analyst Count
- ORKA 8
- AMSF 2
- Target Price
- ORKA $39.71
- AMSF $59.50
- AVG Volume (30 Days)
- ORKA 364.0K
- AMSF 143.6K
- Earning Date
- ORKA 08-15-2025
- AMSF 07-24-2025
- Dividend Yield
- ORKA N/A
- AMSF 10.56%
- EPS Growth
- ORKA N/A
- AMSF N/A
- EPS
- ORKA N/A
- AMSF 2.48
- Revenue
- ORKA N/A
- AMSF $301,216,000.00
- Revenue This Year
- ORKA N/A
- AMSF $1.69
- Revenue Next Year
- ORKA N/A
- AMSF $6.54
- P/E Ratio
- ORKA N/A
- AMSF $17.81
- Revenue Growth
- ORKA N/A
- AMSF N/A
- 52 Week Low
- ORKA $5.49
- AMSF $42.48
- 52 Week High
- ORKA $52.32
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- AMSF 47.66
- Support Level
- ORKA N/A
- AMSF $42.80
- Resistance Level
- ORKA N/A
- AMSF $44.19
- Average True Range (ATR)
- ORKA 0.00
- AMSF 0.91
- MACD
- ORKA 0.00
- AMSF 0.14
- Stochastic Oscillator
- ORKA 0.00
- AMSF 81.55
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums.